Rischio di iperomocisteinemia in pazienti con epilessia, portatori del diplotipo C677T/A1298C della MTHFR
Gaetano Gorgone, Francesco Pisani(University of Messina), Daniela Caccamo(University of Messina), Domenico Italiano(University of Messina), G. Oteri(University of Messina), Salvatore Condello(Indiana University Health), Gia M. Badolato(University of Messina), Pasquale Striano(Great Ormond Street Hospital), Vincenzo Belcastro(Aziende Socio Sanitarie Territoriale Lodi), Laura Rosa Pisani(Regenxbio (United States)), Riccardo Ientile(University of Messina)
Bollettino - Lega italiana contro l'epilessia
January 1, 2005
Cited by 0
Related Papers
Mapping the human genetic architecture of COVID-19
|Nature|2021|1.1k
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
|The American Journal of Human Genetics|2019|310
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|252